Vanguard Group’s Convey Health Solutions Holdings, Inc. CNVY Stock Holding History

Vanguard Group’s Portfolio CNVY Stock Details CNVY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-697,640	Closed	-$7.33M	–	4622
2022 Q3	$7.33M	Buy	697,640 +9,988	+1%	+$105K	﹤0.01%	3110
2022 Q2	$7.15M	Buy	687,652 +79,030	+13%	+$490K	﹤0.01%	3178
2022 Q1	$3.98M	Sell	608,622 -989	-0.2%	-$6.53K	﹤0.01%	3637
2021 Q4	$5.1M	Sell	609,611 -111,403	-15%	-$818K	﹤0.01%	3599
2021 Q3	$6.06M	Buy	721,014 +521,014	+261%	+$4.64M	﹤0.01%	3532
2021 Q2	$2.28M	Buy	+200,000	New	+$2.32M	﹤0.01%	3935

Vanguard Group's CNVY Position: Q4 2022 in Review

Vanguard Group sold out of Convey Health Solutions Holdings, Inc. (CNVY) in Q4 2022, closing a stake of 697,640 shares — an estimated $7.33M sold.

Vanguard Group first reported a position in CNVY in Q2 2021 and held it in 6 quarters. The position peaked at $7.33M in Q3 2022. 0 funds tracked by Wall St. Rank hold CNVY as of Q4 2022.

Vanguard Group reported no remaining Convey Health Solutions Holdings, Inc. position as of Q4 2022 after selling out during the quarter.
Vanguard Group sold 697,640 Convey Health Solutions Holdings, Inc. shares in Q4 2022, an estimated $7.33M.
Vanguard Group first reported a position in Convey Health Solutions Holdings, Inc. in Q2 2021 and held it in 6 quarters.
Vanguard Group's Convey Health Solutions Holdings, Inc. position peaked at $7.33M in Q3 2022.
0 funds tracked by Wall St. Rank held Convey Health Solutions Holdings, Inc. as of Q4 2022.

Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.